| __timestamp | AstraZeneca PLC | Intra-Cellular Therapies, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 5579000000 | 21226345 |
| Thursday, January 1, 2015 | 5997000000 | 87718074 |
| Friday, January 1, 2016 | 5890000000 | 93831530 |
| Sunday, January 1, 2017 | 5757000000 | 79419009 |
| Monday, January 1, 2018 | 5932000000 | 132166913 |
| Tuesday, January 1, 2019 | 5958000000 | 89124838 |
| Wednesday, January 1, 2020 | 5991000000 | 65782137 |
| Friday, January 1, 2021 | 9736000000 | 88845513 |
| Saturday, January 1, 2022 | 9762000000 | 134715000 |
| Sunday, January 1, 2023 | 10935000000 | 180142000 |
| Monday, January 1, 2024 | 13583000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical landscape, research and development (R&D) is the lifeblood of innovation. Over the past decade, AstraZeneca PLC and Intra-Cellular Therapies, Inc. have demonstrated contrasting R&D investment strategies. AstraZeneca, a global biopharmaceutical giant, has consistently invested heavily in R&D, with expenditures peaking at approximately $10.9 billion in 2023, marking a 96% increase from 2014. This robust investment underscores AstraZeneca's commitment to pioneering new treatments and maintaining its competitive edge.
Conversely, Intra-Cellular Therapies, a smaller player in the industry, has shown a more modest yet steady increase in R&D spending. From 2014 to 2023, their R&D expenses grew by over 740%, reaching $180 million. This growth reflects their strategic focus on niche therapeutic areas, aiming to carve out a significant market presence. The contrasting R&D strategies of these companies highlight the diverse approaches to innovation in the pharmaceutical sector.
Research and Development Expenses Breakdown: AstraZeneca PLC vs Zoetis Inc.
Cost of Revenue Comparison: AstraZeneca PLC vs Intra-Cellular Therapies, Inc.
AstraZeneca PLC vs Verona Pharma plc: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Rhythm Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for AstraZeneca PLC and Iovance Biotherapeutics, Inc.
Research and Development Investment: AstraZeneca PLC vs Celldex Therapeutics, Inc.
Sanofi or Intra-Cellular Therapies, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Regeneron Pharmaceuticals, Inc. and Intra-Cellular Therapies, Inc.
Research and Development Investment: Incyte Corporation vs Intra-Cellular Therapies, Inc.
Comparing Innovation Spending: Intra-Cellular Therapies, Inc. and Bio-Techne Corporation
R&D Insights: How Intra-Cellular Therapies, Inc. and Alpine Immune Sciences, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Intra-Cellular Therapies, Inc. and CymaBay Therapeutics, Inc.